Αποτελέσματα Αναζήτησης
12 Οκτ 2020 · Inherent in the quest for new anticoagulants is minimizing the risk of bleeding while on therapy. The challenge in differentiating hemostasis from thrombosis is that they reflect different outcomes originating from the same processes.
29 Απρ 2016 · The direct oral anticoagulants (DOACs) represent a major advance in oral anticoagulant therapy and have replaced the vitamin K antagonists as the preferred treatment for many indications.
Abstract. FXI (factor XI) and FXII (factor XII) have emerged as targets for new anticoagulants that have the potential to be both more efficacious and safer than the currently available direct oral anticoagulants for the prevention and treatment of venous thromboembolism.
14 Ιουλ 2020 · Clinical evaluation of new anticoagulants often starts in patients undergoing joint replacement surgery because such patients are at high risk of postoperative venous thromboembolism, particularly asymptomatic deep vein thrombosis (DVT), which can be detected on routine venography.
1 Μαρ 2015 · This review provides a concise summary of the novel oral anticoagulants for dermatologists with particular emphasis on: (1) the pharmacokinetic properties of these drugs and how they differ from warfarin, (2) suggested management during cutaneous surgery, (3) adverse drug interactions with commonly prescribed medications in dermatology, and (4 ...
With the goal of developing a new class of anticoagulants associated with a lower risk of bleeding than currently available agents, dozens of drugs targeting the contact system are now in development.
25 Φεβ 2015 · This review discusses the new anticoagulants such as dabigatran, edoxaban, rivaroxaban, and apixaban, and provides practical and easy-to-use algorithms for application in the clinical routine specially focused on AF prophylaxis.
